Histopathological characteristics and coexpression of p53 and p16INK4a proteins in renal cancer

Histopathological characteristics and coexpression of p53 and p16INK4a proteins in renal cancer

Background/Aim. Renal carcinoma represents histologically heterogeneous group of malignant tumors, with various clinical aggressiveness. The frequency of p53 mutation in primal renal carcinoma is rare, although there are information about its heterogeneous accumulation. The loss of protein p16 expre...

Full description

Bibliographic Details
Main Authors:	Živković Slađana, Kostov Miloš, Pavlović Svetlana, Mijović Žaklina
Format:	Article
Language:	English
Published:	Military Health Department, Ministry of Defance, Serbia 2008-01-01
Series:	Vojnosanitetski Pregled
Subjects:	carcinoma renal cells tumor suppressor protein p53 cyclin dependent kinase inhibitor p16 immunohistochemistry
Online Access:	http://www.doiserbia.nb.rs/img/doi/0042-8450/2008/0042-84500811820Z.pdf

Similar Items

Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders
by: Aline Correa Abrahao, et al.
Published: (2011-02-01)

Effect of human papillomavirus on cell cycle-related proteins p16INK4A, p21waf1/cip1, p53 and cyclin D1 in sinonasal inverted papilloma and laryngeal carcinoma. An in situ hybridization study
by: Olga Stasikowska-Kanicka, et al.
Published: (2011-04-01)

Effect of human papillomavirus on cell cycle-related proteins p16INK4A, p21waf1/cip1, p53 and cyclin D1 in sinonasal inverted papilloma and laryngeal carcinoma. An <i>in situ</i> hybridization study
by: Marian Danilewicz, et al.
Published: (2011-04-01)

Coexpression of p53 and Ki 67 and lack of c-erbB2 expression in oral leukoplakias in India
by: Priya Kumar, et al.
Published: (2012-06-01)

Expression of the cell cycle regulation proteins p53 and p21WAF1 in different types of non-dysplastic leukoplakias
by: Fernanda Visioli, et al.
Published: (2012-06-01)

Expressão de p53, p16 E COX-2 em carcinoma escamoso de esôfago e associação histopatológica p53, p16 E COX-2 expression in esophageal squamous cell carcinoma and histopathological association
by: Izabella Paz Danezi Felin, et al.
Published: (2008-12-01)

Expression of p53 Protein in Colorectal Cancer and Association With Prognostic Factors in Northeast Iran
by: Ramin Azarhoush, et al.
Published: (2018-03-01)

p53 & Cyclin D1 expression in surgically resected clear margins of oral squamous cell carcinoma
by: Snega Thamilselvan, et al.
Published: (2021-05-01)

Immunohistochemistry Assessment of P53 Protein in Basal Cell Carcinoma
by: Reza Ghaderi Fatemeh Haghighi
Published: (2005-12-01)

Unravelling Multifaceted p73: From Cell Kinetics to Therapeutics
by: Anitha Dayakar, et al.
Published: (2022-07-01)

Protein p16 role in seborrheic keratosis
by: Alexandra K. Alexandrova, et al.
Published: (2016-10-01)

Mutant P53 expression in chronic myeloid leukemia
by: Areej E. Kadhom, et al.
Published: (2013-07-01)

Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma
by: Michaela Plath, et al.
Published: (2018-09-01)

EXPRESSION OF OCT-4, P53, P16 AND KI-67, WITH HPV ASSOCIATED PRECANCER AND CANCER OF THE CERVIX
by: E A Kogan, et al.
Published: (2016-03-01)

The role of cyclin D1, BCL-2, p53 and Ki-67 in epithelial cells in the etiopathogenesis of pterygium
by: Elçin Süren, et al.
Published: (2021-01-01)

Immunohistochemical expression of p63, p53 in urinary bladder carcinoma
by: Ali Koyuncuer
Published: (2013-01-01)

Recent Synthetic Approaches towards Small Molecule Reactivators of p53
by: Jerson L. Silva, et al.
Published: (2020-04-01)

The Interplay Between Tumor Suppressor p53 and Hypoxia Signaling Pathways in Cancer
by: Cen Zhang, et al.
Published: (2021-02-01)

Influência da localização do tumor na expressão tecidual da proteína p53 em doentes com câncer colorretal: estudo de 100 casos
by: Carlos Augusto Real Martinez, et al.

Study on the prognostic value of p53 and PTEN immunomarkers for endometrial cancer using immunohistochemistry
by: Heidar Ali Esmaieli, et al.
Published: (2017-11-01)

p53 Point Mutation is Rare in Meningiomas from Singaporean Patients
by: Asha Das
Published: (2005-01-01)

P53 gene mutation and protein expression in ameloblastomas
by: Karima Akool Al-Salihi, et al.
Published: (2015-11-01)

Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations
by: Ilay Caliskan, et al.
Published: (2024-03-01)

Histopathology and Prognostic Indices of Carcinoma Breast with Special Reference to p53 Marker
by: Rajesh Kanna Nandagopal Radha, et al.
Published: (2014-07-01)

Imunolocalização das proteínas dos genes supressores de tumores TP53 e p16CDKN2 no front invasivo do carcinoma epidermóide de cavidade bucal Immunolocalization of TP53 and p16CDKN2 tumour suppressor genes proteins in invasive front of oral epidermoid carcinoma
by: Alfredo Maurício Batista De-Paula, et al.
Published: (2006-08-01)

Expression of p53 and p21 in bladder carcinoma of Iraqi patients
by: Rawaa Al Chalabi, et al.
Published: (2019-06-01)

The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis
by: Keerthana Gnanapradeepan, et al.
Published: (2018-04-01)

Partial p53 reactivation is sufficient to induce cancer regression
by: Boris Klimovich, et al.
Published: (2022-03-01)

Mutant p53 and ETS2, a tale of reciprocity
by: Luis Alfonso Martinez
Published: (2016-02-01)

P16 expression in human breast carcinoma and its relationship to clinicopathological parameters
by: Fereshteh Mohammadizadeh, et al.
Published: (2023-01-01)

Comparative immunohistochemical characteristics of expression of estrogen receptors-alpha, progesterone receptors, p16, p53, Ki-67 and caspase 3 in invasive endometrial adenocarcinoma and normal proliferative endometrium
by: V. A. Tumanskiy, et al.
Published: (2016-04-01)

p53: A double-edged sword in tumor ferroptosis
by: Haixia Ji, et al.
Published: (2022-03-01)

The Role of P53 in Oral Cancer - A Review
by: C Poornima, et al.
Published: (2005-01-01)

P53 mRNA in- Situ Hybridization analysis and Immunohistochemical Expression in Lung Cancer: A Comparative Study.
by: Ban A. Abdul-Majeed
Published: (2010-10-01)

The Expression of E6 HPV, P53 and P16ink4a at Well, Moderately, and Poorly Differentiated Cervical Adenocarcinoma
by: Gondo Mastutik, et al.
Published: (2021-01-01)

Comparative analysis of EZH2, p16 and p53 expression in uterine carcinosarcomas
by: Evelin Makk, et al.
Published: (2023-12-01)

Expression of P53 protein in premalignancies and squamous cell carcinoma of the oral cavity
by: Poornima Chandra, et al.
Published: (2012-01-01)

Mutant p53 as an Antigen in Cancer Immunotherapy
by: Navid Sobhani, et al.
Published: (2020-06-01)

Non-Small Cell Lung Carcinoma: Cyclin D1, bcl-2, p53, Ki-67 and Her-2 Proteins Expression in Resected Tumors
by: Svjetlana Radović, et al.
Published: (2007-08-01)

Prognostic significance of p16, VEGF, and p53 expression patterns, Krouse stage, and smoking status in sinonasal inverted papillomas
by: Betul Peker Cengiz
Published: (2022-01-01)